References for: association
Full identifier: http://purl.org/np/RAOBgKeDknwaUkV-tJZnH9QdUdIT9hj67pv3NwXTIUHIY#association
Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
---|---|---|---|---|---|---|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP.
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
0000-0002-7641-6446
|
2021-08-24T20:13:50.640Z
|